Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Kedudukan dalam Saham #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Harga Saham
$4.84
Modal Pasaran
$633.18M
Perubahan (1 hari)
3.20%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Exscientia plc (EXAI)

Kategori

Healthcare
Nisbah P/B bagi Exscientia plc (EXAI)
Nisbah P/B pada April 2026 TTM: 1.26
Menurut laporan kewangan dan harga saham terkini Exscientia plc, nisbah P/B semasa (TTM) ialah 1.26. Pada akhir 2022, nisbah P/B syarikat ialah 1.36.
Sejarah nisbah P/B untuk Exscientia plc dari 2019 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 1.26 -27.40%
2023 1.74 28.33%
2022 1.36 -67.63%
2021 4.20 -85.97%
2020 29.94 -64.81%
2019 85.08 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.2875 318.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.074 380.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.5436 101.35%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5196 257.76%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5468 101.60%
AU